Protembis
Latest round
- Series B
Last raised
- Mar 2024
Total raised
- $42M
Investors
- 13
About Protembis
Protembis GmbH develops advanced medical solutions focused on brain protection during cardiology interventions. Conrad Rasmus, the founder, has a background in medical technology innovation.160 mn.Protembis GmbH specializes in the development of innovative medical technologies aimed at reducing the risk of brain injuries during cardiology procedures, particularly those involving transcatheter aortic valve replacement (TAVR). Their flagship product, the ProtEmbo® Cerebral Protection System (CPS), is engineered to ensure comprehensive brain protection during TAVR procedures, effectively mitigating the occurrence of silent brain infarcts that can lead to covert clinical strokes and potential long-term cognitive decline. Clinical studies have demonstrated the efficacy and safety of the ProtEmbo system, with many patients showing no clinically meaningful brain lesions post-procedure.Protembis operates a B2B model, engaging directly with hospitals and healthcare institutions that perform TAVR procedures. Revenue is generated through the sale of the ProtEmbo system, which is utilized during these interventions to improve patient outcomes by minimizing the risk of cerebral complications. The company explores partnerships and collaborations with medical device distributors and healthcare organizations to broaden its market reach. The company is actively developing new products designed to improve patient safety during cardiac procedures and aims to expand into additional markets across Europe and North America by 2025.
Who invested in Protembis
13 investors across 2 rounds
See all investors in Protembis
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Protembis
Who invested in Protembis?
Protembis has 13 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Protembis raised?
Protembis has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Protembis last raise money?
Protembis's most recent round on record is a Series B, in Mar 2024.
What does Protembis do?
Protembis GmbH develops advanced medical solutions focused on brain protection during cardiology interventions.
Where is Protembis headquartered?
Protembis is headquartered in Aachen, Germany.
Which VCs invest in companies like Protembis?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back medical devices & equipment companies at Protembis's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series B
Raising like Protembis? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.